EMERALD CLINICAL TRIALS, INC.
OVERLAND PARK, KS

GEORGE CLINICAL, INC., officially registered in Florida with the filing number F17000003025, is a Full Service Contract Research Organization (CRO) specializing in clinical trials. It operates with headquarters situated at 10975 BENSON DR STE 200, Overland Park, KS, and has an online presence through its website: georgeclinical.com. Founded on July 5, 2017, George Clinical distinguishes itself by emphasizing scientific leadership across the Asia-Pacific region, with notable operations in countries like India, China, Hong Kong, and others. The company uniquely integrates scientific expertise from the outset of clinical studies, enhancing patient recruitment and retention through peer-to-peer engagement with key investigators. With services spanning numerous therapeutic disciplines, George Clinical excels in Phase I-II trials, offering comprehensive support—from study design and protocol development to regulatory affairs and data management. The use of proprietary technologies such as Site Tracking and Recruitment (STAR) further strengthens their capability to match trial requirements with suitable sites efficiently. The leadership team is led by Chief Executive Officer Marisa Petersen, who brings an extensive background in Clinical Pharmacology with over two decades of experience across regulatory affairs, clinical research, and project management. Guided by The George Institute's mission, the company aims to improve global health outcomes through science-driven clinical trials that address unmet medical needs. With last annual reporting on April 28, 2024, George Clinical continues its strategic expansion and commitment to delivering excellence in the highly complex landscape of real-world and late-phase clinical research.